jcm-logo

Journal Browser

Journal Browser

Gender Dysphoria: Current Approach to Clinical Care and Research

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".

Deadline for manuscript submissions: closed (25 October 2024) | Viewed by 3028

Special Issue Editors


E-Mail Website
Guest Editor

E-Mail Website
Guest Editor
Section of Endocrinology, University of Palermo, 90127 Palermo, Italy
Interests: sex hormones; gender dysphoria; hypogonadism; metabolism; growth hormone; puberty disorders

Special Issue Information

Dear Colleagues,

Gender dysphoria can be described as a condition of discomfort and persistent suffering caused by feeling one's gender identity is different from one's biological sex. Subjects with gender dysphoria present a marked inconsistency between the gender attributed to them at the time of birth (generally, reference is made to phenotypic sex) and the gender they experience/express. Gender identity disorder causes discomfort toward one's own body, perceived as distant and alien. Although not all subjects may suffer from this inconsistency, the majority suffer from it because they are unable to implement the physical interventions required for hormonal and sometimes even surgical treatment.

Individuals with this condition have the opportunity to receive psychological support and medical assistance, in order to start a process that will lead to a change in their personal and/or anatomical sex. Among the various interventions, in order to modify their secondary sexual characteristics so that they align with their gender identity, hormone replacement therapy for trans people consists of taking hormones (feminizing such as estrogen or masculinizing such as testosterone). Scientific interest in better characterizing and assisting the hormonal transition process of trans people has recently increased, both from a psychological and general health point of view. The distress caused by gender dysphoria is typically described as a combination of anxiety, depression, irritability, self-harm, suicidal ideation (up to 60% of cases), eating disorders (mainly caused by the attempt to control the development of one's body and to limit the typical changes in a greater bodily "sexual characterization"), substance abuse and a pervasive sense of not feeling comfortable in one's own body. Some subjects present internalized transphobia (negative feelings toward their condition), often presenting poor acceptance, low self-esteem, feelings of inferiority and guilt, shame and identification with denigrating stereotypes. Individuals who have experienced harassment and violence may later experience post-traumatic stress disorder. Therefore, in many cases, long-term psychotherapeutic assistance is necessary. This condition is therefore of considerable interest because it involves many clinical areas, both in diagnosis and in hormonal, surgical, psychological and psychiatric treatment. This Special Issue aims to collate research articles and reviews regarding the clinical diagnosis, monitoring and treatment of gender dysphoria.

Prof. Dr. Michele Roccella
Dr. Stefano Radellini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gender identity
  • childhood
  • gender dysphoria
  • persistence
  • psychosexual development
  • treatment
  • autism spectrum disorder
  • co-morbidity
  • co-occurrence
  • gender identity disorder
  • adolescents
  • cross-hormone treatment
  • rapid-onset gender dysphoria
  • sex ratio
  • suicidality

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

15 pages, 2924 KiB  
Article
Beyond the Gender Binarism: Neural Correlates of Trans Men in a Functional Connectivity–Resting-State fMRI Pilot Study
by Giuseppe Maniaci, Giorgio Collura, Caterina La Cascia, Tommaso Piccoli, Eleonora Bongiorno, Ilaria Barresi, Maurizio Marrale, Cesare Gagliardo, Alessandra Giammanco, Valeria Blandino, Crocettarachele Sartorio, Stefano Radellini, Laura Ferraro, Francesca Toia, Giovanni Zabbia, Giulia Bivona, Massimo Midiri, Marcello Ciaccio, Daniele La Barbera, Adriana Cordova and Diego Quattroneadd Show full author list remove Hide full author list
J. Clin. Med. 2024, 13(19), 5856; https://doi.org/10.3390/jcm13195856 - 30 Sep 2024
Viewed by 1073
Abstract
Introduction: Several studies have investigated the specific neural correlates of trans people, highlighting mixed results. This study aimed to compare the presence of specific functional connectivity and differences in cognitive profile and hormone levels in trans men diagnosed with gender dysphoria (GD), [...] Read more.
Introduction: Several studies have investigated the specific neural correlates of trans people, highlighting mixed results. This study aimed to compare the presence of specific functional connectivity and differences in cognitive profile and hormone levels in trans men diagnosed with gender dysphoria (GD), and a homogeneous group of cisgender men and cisgender women. Methods: A total of 42 participants (19 trans men, 11 cisgender men, and 12 cisgender women) underwent a resting state fMRI and were measured for blood levels of testosterone, estradiol, and progesterone. A neuropsychological battery evaluated executive functions, attention, visual-perceptual ability, verbal fluency, manual preference, and general intelligence. Results: Trans men showed weaker functional connectivity in the precentral gyrus, subcallosal cortex, paracingulate gyrus, temporal pole, and cingulate gyrus than cisgender men (p < 0.01). Trans men performed worse than cisgender men in verbal and visuospatial working memory but similarly to cisgender women (p < 0.05). In trans men, functional connectivity of the precentral gyrus correlated positively with testosterone (r = 0.459, p = 0.064) and negatively with estradiol (r = −0.654, p = 0.004) and progesterone blood levels (r = −0.475, p = 0.054). The cluster involving the subcallosal cortex showed a positive correlation with testosterone (r = 0.718, p = 0.001), and a negative correlation with estradiol (r = −0.602, p = 0.011). The functional connectivity from a cluster involving the paracingulate gyrus showed a positive correlation with testosterone (r = 0.592, p = 0.012). Conclusions: This study highlights the importance of overpassing the binary model by underlining the presence of neural pathways that could represent the peculiarity of the neural profile of people with GD. Full article
(This article belongs to the Special Issue Gender Dysphoria: Current Approach to Clinical Care and Research)
Show Figures

Figure 1

Review

Jump to: Research

17 pages, 1085 KiB  
Review
The Potential Health Risks and Benefits of Progesterone in the Transgender Woman Population—A Narrative Review
by Simone Szymczyk, Katarzyna Mączka, Lidia Mądrzak, Monika Grymowicz and Roman Smolarczyk
J. Clin. Med. 2024, 13(22), 6795; https://doi.org/10.3390/jcm13226795 - 12 Nov 2024
Viewed by 1260
Abstract
Introduction: Currently, progesterone is notably absent from conventional feminizing hormone therapies for transgender women. Anecdotal reports indicate the potential for health advantages following the incorporation of progesterone into treatment regimens. The primarily female hormone, progesterone naturally surges in women during the menstrual luteal [...] Read more.
Introduction: Currently, progesterone is notably absent from conventional feminizing hormone therapies for transgender women. Anecdotal reports indicate the potential for health advantages following the incorporation of progesterone into treatment regimens. The primarily female hormone, progesterone naturally surges in women during the menstrual luteal phase. When administered exogenously, it may expedite bodily changes that are pivotal for gender transition. Progesterone holds promise as a potential remedy for various health conditions prevalent in the transgender woman population. Methods: This narrative review synthesizes existing literature and presents a comprehensive account of the administration of exogenous progesterone in transgender women. A literature search was conducted using the PubMed, Embase, ScienceDirect, and ResearchGate databases. The following keywords were used in the search: progesterone, transgender, breast neoplasms, lactation, prostate, testicular neoplasms, and thrombosis. These terms were combined using Boolean operators. The results of the initial search were screened by three independent reviewers based on their relevance to the topic under study. Results: A total of 104 studies were initially identified as meeting the criteria for inclusion. Following an assessment based on the contents of the title, abstract, and full text, 39 studies were deemed eligible for inclusion. A critical examination of health outcomes was conducted across key sections, including breast development, mental health, lactation, cancer risk (breast and prostate), thrombosis, and nervous and other systems. Discussion: The use of progesterone in the transgender woman population is a topic that has yet to be sufficiently researched. The limited sample size, short follow-up periods, and lack of randomization restrict the potential for achieving a robust scientific evidence base. In order to gain a fuller understanding of this topic, findings from studies on contraception, hormone replacement therapy, and animal models were considered. Conclusions: Progesterone may have a beneficial effect on the bodies of transgender women without significant adverse health effects. Further investigation through well-designed studies is recommended. Randomized controlled trials that include various dosages, broad and long-term effects, and precise demographics are needed. There is an immediate need for more knowledge to create appropriate patent and clinical practice guidelines. Full article
(This article belongs to the Special Issue Gender Dysphoria: Current Approach to Clinical Care and Research)
Show Figures

Figure 1

Back to TopTop